Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;5(9):e2229716.
doi: 10.1001/jamanetworkopen.2022.29716.

Association Between Sex-Specific Risk Factors and Risk of New-Onset Atrial Fibrillation Among Women

Affiliations

Association Between Sex-Specific Risk Factors and Risk of New-Onset Atrial Fibrillation Among Women

Zuolin Lu et al. JAMA Netw Open. .

Abstract

Importance: Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with different epidemiological and pathophysiological processes for women vs men and a poorer prognosis for women. Further investigation of sex-specific risk factors associated with AF development in women is warranted.

Objective: To investigate the linear and potential nonlinear associations between sex-specific risk factors and the risk of new-onset AF in women.

Design, setting, and participants: This population-based cohort study obtained data from the 2006 to 2010 UK Biobank study, a cohort of more than 500 000 participants aged 40 to 69 years. Participants were women without AF and history of hysterectomy and/or bilateral oophorectomy at baseline. Median follow-up period for AF onset was 11.6 years, and follow-up ended on October 3, 2020.

Exposures: Self-reported, sex-specific risk factors, including age at menarche, history of irregular menstrual cycle, menopause status, age at menopause, years after menopause, age at first live birth, years after last birth, history of spontaneous miscarriages, history of stillbirths, number of live births, and total reproductive years.

Main outcomes and measures: The primary outcome was new-onset AF, which was defined by the use of International Statistical Classification of Diseases and Related Health Problems, Tenth Revision code I48.

Results: A total of 235 191 women (mean [SD] age, 55.7 [8.1] years) were included in the present study. During follow-up, 4629 (2.0%) women experienced new-onset AF. In multivariable-adjusted models, history of irregular menstrual cycle was associated with higher AF risk (hazard ratio [HR], 1.34; 95% CI, 1.01-1.79). Both early menarche (age 7-11 years; HR, 1.10 [95% CI, 1.00-1.21]) and late menarche (age 13-18 years; HR, 1.08 [95% CI, 1.00-1.17]) were associated with AF incidence. Early menopause (age 35-44 years; HR, 1.24 [95% CI, 1.10-1.39]) and delayed menopause (age ≥60 years; HR, 1.34 [95% CI, 1.10-1.78]) were associated with higher risk of AF. Compared with women with 1 to 2 live births, those with 0 live births (HR, 1.13; 95% CI, 1.04-1.24) or 7 or more live births (HR, 1.67; 95% CI, 1.03-2.70) both had significantly higher AF risk.

Conclusions and relevance: Results of this study suggest that irregular menstrual cycles, nulliparity, and multiparity were associated with higher risk of new-onset AF among women. The results highlight the importance of taking into account the reproductive history of women in devising screening strategies for AF prevention.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Roeters van Lennep reported receiving grants from Novartis, Amryt, Dutch Heart Foundation, and Dutch Research Organization outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flowchart of the Study Population
AF indicates atrial fibrillation.
Figure 2.
Figure 2.. Nonlinear Association Between Sex-Specific Risk Factors and Risk of New-Onset Atrial Fibrillation
Model was adjusted for baseline age, race and ethnicity, educational level, body mass index, total cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, diastolic blood pressure, smoking status, history of diabetes, history of coronary heart disease, history of heart failure, history of stroke, use of blood pressure–lowering medication, and use of cholesterol-lowering medication. Shaded areas indicate 95% CIs. HR indicates hazard ratio.

Comment in

References

    1. Hindricks G, Potpara T, Dagres N, et al. ; ESC Scientific Document Group . 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612 - DOI - PubMed
    1. Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016;13(6):321-332. doi:10.1038/nrcardio.2016.45 - DOI - PMC - PubMed
    1. Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The use of sex-specific factors in the assessment of women’s cardiovascular risk. Circulation. 2020;141(7):592-599. doi:10.1161/CIRCULATIONAHA.119.043429 - DOI - PMC - PubMed
    1. Cignarella A, Kratz M, Bolego C. Emerging role of estrogen in the control of cardiometabolic disease. Trends Pharmacol Sci. 2010;31(4):183-189. doi:10.1016/j.tips.2010.01.001 - DOI - PubMed
    1. Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33. doi:10.1186/s13293-017-0152-8 - DOI - PMC - PubMed

Publication types